What hope for the future? GNAQ and uveal melanoma.

SISLEY, K, DOHERTY, R and CROSS, Neil (2011). What hope for the future? GNAQ and uveal melanoma. British Journal of Ophthalmology, 95 (5), 620-623.

Full text not available from this repository.
Link to published version:: https://doi.org/10.1136/bjo.2010.182097
Related URLs:

    Abstract

    Uveal melanomas (UM) are aggressive ocular tumours that spread to the liver. They are characterised by alterations of chromosome 3 and 8, which are highly predictive of a poor prognosis. Unfortunately, being able to identify those patients with aggressive disease has not, as yet, translated into improved survival. Recently, mutations of guanine nucleotide-binding protein G(q) subunit alpha (GNAQ, or G-alpha-q), which effectively turn it into a dominantly acting oncogene, have been identified in approximately half of UM. These mutations are specific to UM and other non-cutaneous melanomas, and are not found in normal tissues, thus making them potential therapeutic targets. Here, the authors review the background to GNAQ in UM and explore what makes it such an interesting target for the future treatment of patients.

    Item Type: Article
    Research Institute, Centre or Group - Does NOT include content added after October 2018: Biomolecular Sciences Research Centre
    Identification Number: https://doi.org/10.1136/bjo.2010.182097
    Page Range: 620-623
    Depositing User: Rebecca Jones
    Date Deposited: 25 Jan 2012 10:48
    Last Modified: 09 Oct 2018 12:53
    URI: http://shura.shu.ac.uk/id/eprint/4376

    Actions (login required)

    View Item View Item

    Downloads

    Downloads per month over past year

    View more statistics